Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Aurora Cannabis Inc

Current price
0.52 USD +0.05 USD (+10.61%)
Last closed 0.47 USD
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange NASDAQ
Capitalization 222 465 920 USD
Yield for 12 month -61.76 %
21.11.2021 - 28.11.2021

Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, the Caribbean, South America, and Israel; supply of propagated vegetables and ornamental plants in North America; and distribution and sale of hemp-derived cannabidiol (CBD) products. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried flowers, vapes, dried milled strains, strain-specific extracts, strain specific cannabis oils, and concentrates. Further, it offers recreational cannabis products, such as flowers, vapes, ingestibles, concentrates, extracts, and CBD products; and patient counseling and outreach services. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. Aurora Cannabis Inc. is headquartered in Leduc, Canada. Address: 500 - 10355 Jasper Avenue, Edmonton, AB, Canada, T5J 1Y6


WallStreet Target Price

2.78 USD

P/E ratio

Dividend Yield

Current Year

+163 960 887 USD

Last Year

+181 674 877 USD

Current Quarter

+46 978 036 USD

Last Quarter

+37 197 674 USD

Current Year

+15 722 805 USD

Last Year

-15 969 480 USD

Current Quarter

+25 518 723 USD

Last Quarter

+3 251 972 USD

Key Figures ACB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -143 760 000 USD
Operating Margin TTM -4.56 %
PE Ratio
Return On Assets TTM -9.17 %
PEG Ratio
Return On Equity TTM -102.67 %
Wall Street Target Price 2.78 USD
Revenue TTM 225 179 008 USD
Book Value 1.2 USD
Revenue Per Share TTM 0.74 USD
Dividend Share
Quarterly Revenue Growth YOY 30.4 %
Dividend Yield
Gross Profit TTM 21 225 000 USD
Earnings Share -5.84 USD
Diluted Eps TTM -5.84 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY -91.7 %
Profit Margin

Dividend Analytics ACB

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ACB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:12
Payout Ratio
Last Split Date 11.05.2020
Dividend Date 11.05.2020

Stock Valuation ACB

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 1.0366
Price Sales TTM 0.988
Enterprise Value EBITDA -0.134
Price Book MRQ 0.5987

Financials ACB

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators ACB

For 52 weeks

0.41 USD 1.48 USD
50 Day MA 0.5 USD
Shares Short Prior Month 39 205 251
200 Day MA 0.59 USD
Short Ratio 4.61
Shares Short 39 686 439
Short Percent 20.42 %